This company listing is no longer active
Resumen de acción 0PJ
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Allena Pharmaceuticals, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.01 |
| 52 Week High | US$0.51 |
| 52 Week Low | US$0.002 |
| Beta | 1.53 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -97.14% |
| 3 Year Change | -99.58% |
| 5 Year Change | n/a |
| Change since IPO | -99.91% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 0PJ | DE Biotechs | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -5.9% | -1.7% |
| 1Y | -97.1% | -21.4% | -0.2% |
Rentabilidad vs. Industria: 0PJ underperformed the German Biotechs industry which returned 9.6% over the past year.
Rentabilidad vs. Mercado: 0PJ underperformed the German Market which returned -14% over the past year.
Volatilidad de los precios
| 0PJ volatility | |
|---|---|
| 0PJ Average Weekly Movement | 197.4% |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 0PJ's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 0PJ's weekly volatility has increased from 120% to 197% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2011 | 12 | n/a | www.allenapharma.com |
Resumen de fundamentos de Allena Pharmaceuticals, Inc.
| Estadísticas fundamentales de 0PJ | |
|---|---|
| Capitalización bursátil | €1.55m |
| Beneficios(TTM) | -€40.00m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está 0PJ sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 0PJ | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$43.30m |
| Beneficios | -US$43.30m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.35 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 131.1% |
¿Cómo se ha desempeñado 0PJ a largo plazo?
Ver rendimiento histórico y comparativa